학술논문
5-(Trifluoromethyl)-1,2,4-oxadiazole (TFMO)-based highly selective class IIa HDAC inhibitors exhibit synergistic anticancer activity in combination with bortezomib
Document Type
Article
Author
Source
In: European Journal of Medicinal Chemistry . (European Journal of Medicinal Chemistry, 5 January 2024, 263)
Subject
Language
English
ISSN
17683254
02235234
02235234